头颈癌后第二原发甲状腺癌的放疗风险分析
基于SEER数据库1975-2014年127,563例头颈癌幸存者的回顾性分析显示,仅0.2%(229例)发生第二原发甲状腺癌,发生率为每10万人年26.1例;放疗、手术和化疗均未显著增加第二原发甲状腺癌风险。
要点
- 头颈癌后第二原发甲状腺癌发生率极低,为每10万人年26.1例。
- 放疗与第二原发甲状腺癌风险无显著关联(aHR=0.92,95%CI 0.68-1.25)。
- 年龄增长和男性与第二原发甲状腺癌风险降低相关。
核心结论
- 头颈癌后第二原发甲状腺癌发生率很低,既往放疗未显著增加风险。
研究设计与样本
- 回顾性数据分析,查询SEER数据库1975-2014年头颈癌病例(N=127,563)。
主要发现
- 仅0.2%(n=229)头颈癌幸存者发生第二原发甲状腺癌,发生率为每10万人年26.1例。
- 诊断年龄每增加1岁,第二原发甲状腺癌风险降低3%(aHR=0.97,95%CI 0.96-0.98)。
- 男性发生第二原发甲状腺癌风险较低(aHR=0.73,95%CI 0.55-0.96)。
- 放疗(aHR=0.92,95%CI 0.68-1.25)、手术(aHR=0.79,95%CI 0.56-1.11)、化疗(aHR=1.13,95%CI 0.76-1.69)与第二原发甲状腺癌风险无显著关联。
- 敏感性分析同样未发现治疗与第二原发甲状腺癌风险之间的关联。
临床怎么用
- 头颈癌幸存者发生第二原发甲状腺癌的风险很低,放疗史不构成显著风险增加因素。
局限性
- 需要更多研究来理解美国甲状腺癌发病率上升的原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Radiation is thought to increase risk of developing second primary thyroid cancer (SPTC). This study estimated the rate of SPTC following index head and neck cancer (HNC) and determined whether radiation treatment among HNC survivors increased SPTC risk. STUDY DESIGN: Retrospective data analysis. METHOD: The Surveillance, Epidemiology, and End Results database (1975-2014) was queried for cases of index HNC (N = 127,563) that developed SPTC. Adjusted multivariable competing risk proportional hazards model tested risk of developing a SPTC following index HNC. Sensitivity analyses using proportional hazards models were also performed restricting data to patients who 1) received both radiation and chemotherapy and 2) radiation alone. RESULTS: Only 0.2% of index HNC survivors (n = 229) developed SPTC, yielding a rate of 26.1 per 100,000 person-years. For every increasing year of age at diagnosis, patients were 3% less likely to develop an SPTC (adjusted hazard ratio [aHR] = 0.97, 95% CI: 0.96-0.98). Males were also less likely to develop an SPTC (aHR = 0.73, 95% CI: 0.55-0.96). Radiation (aHR = 0.92, 95% CI: 0.68-1.25), surgery (aHR = 0.79, 95% CI: 0.56-1.11), and chemotherapy (aHR = 1.13, 95% CI: 0.76-1.69) were not significantly associated with developing SPTC. The sensitivity models also did not find an association between treatment and risk of SPTC. CONCLUSIONS: Rate of developing SPTC following index HNC was very low, and previous exposure to radiation did not significantly increase risk in our study population. More studies are needed to understand the increasing incidence of thyroid cancer across the United States. LEVEL OF EVIDENCE: NA Laryngoscope, 129:1014-1020, 2019.
引用
- Polednik KM, Simpson MC, Adjei Boakye E, et al. Radiation and Second Primary Thyroid Cancer Following Index Head and Neck Cancer. Laryngoscope. 2018. PMID: 30208210. doi:10.1002/lary.27467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。